N-methyl-D-aspartate Receptor Antagonist Ketamine Impairs Action-monitoring Activity in the Prefrontal Cortex

被引:10
|
作者
Skoblenick, Kevin [1 ]
Everling, Stefan [1 ]
机构
[1] Univ Western Ontario, London, ON N6A 3K7, Canada
基金
加拿大健康研究院;
关键词
ANTERIOR CINGULATE CORTEX; ERROR-RELATED NEGATIVITY; SCHIZOPHRENIC-PATIENTS; VOLUNTARY CONTROL; ANTISACCADE TASK; EYE-MOVEMENTS; PERFORMANCE; SACCADES; MONKEY; ECCENTRICITY;
D O I
10.1162/jocn_a_00519
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Failures in monitoring of self-generated actions are thought to underlie the positive symptoms in schizophrenia. It has been hypothesized that these deficits may be caused by a dysfunction of N-methyl-D-aspartate receptors (NMDARs). Here we recorded the activity of prefrontal neurons in monkeys performing an antisaccade task, while we administered a sub-anesthetic dose of the noncompetitive NMDAR antagonist ketamine. Many neurons discriminated between correct anti-saccades and response errors in their postresponse activity. Ketamine increased the activity for the neurons' nonpreferred response, thereby decreasing the neurons' performance selectivity. Ketamine also affected the monkeys' behavior after an error, consistent with a deficit in error detection. The results show that NMDARs play an important role in action monitoring in primates. The decrease in performance selectivity of prefrontal neurons after ketamine can help to explain the deficits in action monitoring found in humans after ketamine administration and provides support for the hypothesis that an NMDAR dysfunction underlies self-monitoring deficits and psychotic symptoms in schizophrenia.
引用
收藏
页码:577 / 592
页数:16
相关论文
共 50 条
  • [31] Ketamine, an N-methyl-D-aspartate receptor antagonist, inhibits the spinal neuronal responses to distension of the rat urinary bladders
    Castroman, PJ
    Ness, TJ
    [J]. ANESTHESIOLOGY, 2002, 96 (06) : 1410 - 1419
  • [32] DRUG DISCRIMINATION ANALYSIS OF ETHANOL AS AN N-METHYL-D-ASPARTATE RECEPTOR ANTAGONIST
    BALSTER, RL
    GRECH, DM
    BOBELIS, DJ
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 222 (01) : 39 - 42
  • [33] Effects of the N-methyl-D-Aspartate receptor antagonist dextromethorphan on vibrotactile adaptation
    Folger, Stephen E.
    Tannan, Vinay
    Zhang, Zheng
    Holden, Jameson K.
    Tommerdahl, Mark
    [J]. BMC NEUROSCIENCE, 2008, 9 (1)
  • [34] Clozapine blunts N-methyl-D-aspartate antagonist-induced psychosis: A study with ketamine
    Malhotra, AK
    Adler, CM
    Kennison, SD
    Elman, I
    Pickar, D
    Breier, A
    [J]. BIOLOGICAL PSYCHIATRY, 1997, 42 (08) : 664 - 668
  • [35] In silico insight into Amurensinine-an N-Methyl-D-Aspartate receptor antagonist
    Cinthia Fa?anha Wendel
    Queren Hapuque Oliveira Alencar
    Rafaela Viana Vieira
    Kádima Nayara Teixeira
    [J]. World Journal of Pharmacology, 2023, (03) : 25 - 34
  • [36] Alterations of plasma and cerebrospinal fluid glutamate levels in rats treated with the N-methyl-D-aspartate receptor antagonist, ketamine
    Tomiya, Masayuki
    Fukushima, Takeshi
    Kawai, Junko
    Aoyama, Chiaki
    Mitsuhashi, Shogo
    Santa, Tomofumi
    Imai, Kazuhiro
    Toyo'oka, Toshimasa
    [J]. BIOMEDICAL CHROMATOGRAPHY, 2006, 20 (6-7) : 628 - 633
  • [37] Cocaine self-administration disrupted by the N-methyl-D-aspartate receptor antagonist ketamine: a randomized, crossover trial
    E Dakwar
    C L Hart
    F R Levin
    E V Nunes
    R W Foltin
    [J]. Molecular Psychiatry, 2017, 22 : 76 - 81
  • [38] PNEUMOTAXIC MECHANISMS IN THE NONHUMAN PRIMATE - EFFECT OF THE N-METHYL-D-ASPARTATE (NMDA) ANTAGONIST KETAMINE
    PIERREFICHE, O
    FOUTZ, AS
    DENAVITSAUBIE, M
    [J]. NEUROSCIENCE LETTERS, 1990, 119 (01) : 90 - 93
  • [39] Influence of the N-methyl-D-aspartate antagonist memantine on human motor cortex excitabirity
    Schwenkreis, P
    Witscher, K
    Janssen, F
    Addo, A
    Dertwinkel, R
    Zenz, M
    Malin, JP
    Tegenthoff, M
    [J]. NEUROSCIENCE LETTERS, 1999, 270 (03) : 137 - 140
  • [40] Cocaine self-administration disrupted by the N-methyl-D-aspartate receptor antagonist ketamine: a randomized, crossover trial
    Dakwar, E.
    Hart, C. L.
    Levin, F. R.
    Nunes, E. V.
    Foltin, R. W.
    [J]. MOLECULAR PSYCHIATRY, 2017, 22 (01) : 76 - 81